A spokesman for AstraZeneca has responded to reports of vaccine blockages in several European countries due to the perceived danger of its side effects. In a conversation with CNBC, he assured journalists of the safety of the drug.
“Patient safety is a top priority for AstraZeneca. Only highly effective and safe vaccines are approved by regulators, and the AstraZeneca vaccine is one of them. The safety of the vaccine has been extensively studied and (…) has been shown to be generally well tolerated, ”a company spokesman said.
So far, nine European countries have stopped or temporarily limited vaccination with AstraZeneca due to thrombosis in their vaccinated patients. Austria, Estonia, Latvia, Lithuania and Luxembourg have stopped using the drug from a specific batch of one million doses, which was supplied to 17 European countries. At the same time, Denmark, Iceland and Norway have stopped all their supplies of this vaccine.
In total, according to the European Medicines Agency (EMA), 22 cases of thrombosis were recorded in the territory of the association for three million AstraZeneca vaccinated. The regulator does not link this phenomenon with the use of the vaccine, but the investigation of deaths continues.